© 2005 by BMJ Publishing Group Ltd & European League Against Rheumatism
EXTENDED REPORT
Increased Bcl-2/p53 ratio in human osteoarthritic cartilage: a possible role in regulation of chondrocyte metabolism
1 Rheumatology UnitDIMIMP, University of Bari, Italy
2 Orthopaedics Clinic II, University of Bari, Italy
Correspondence to:
Correspondence to:
Professor G Lapadula
Cattedra di Reumatologia, Piazza G Cesare 11, 70124 Policlinico, Bari, Italy; pa1{at}reumbari.uniba.it
Objective: To determine whether Bcl-2, p53, and Fas/CD95 help to control cartilage metabolism.
Methods: Six normal and 14 osteoarthritic (OA) cartilage samples were examined, and two zones from each sample showing the least (Min) and most (Max) anatomical damage were selected. Chondrocytes were isolated by sequential enzymatic digestion and freshly processed. Bcl-2, p53, and Fas/CD95 expression was evaluated by immunofluorescence and FACS analysis; the cell cycle was analysed using propidium iodide, and chondrocyte proliferation assessed by [3H]thymidine incorporation.
Results: Intracellular levels of Bcl-2 were significantly higher in Max (27.5%) than in Min (21%, p<0.01) OA or normal chondrocytes (18.5%, p<0.01). Intracellular p53 expression was significantly decreased in Max (25.5%) compared with Min (37%, p<0.01) OA or normal cartilage (41.5%, p<0.05). Fas/CD95 receptor expression on surface chondrocytes did not significantly differ between OA and normal cartilage. Cell cycle analysis showed that the proportion of activated chondrocytes in the S phase was significantly higher in Max (69%) than in Min (49%) OA or normal cartilage (43%). The prevalence of proliferating chondrocytes progressively increased according to the degree of OA damage (mean (SEM) Min 1247 (260), Max 2423 (460), p<0.05). Chondrocyte [3H]thymidine uptake correlated positively with Bcl-2 (rs = 0.62, p = 0.009) and correlated inversely with p53 levels (rs = 0.55, p = 0.02).
Conclusions: Bcl-2 and p53 play a part in apoptosis, but also help to regulate chondrocyte growth and differentiation. Whereas Bcl-2 promotes cell survival, p53 can arrest cell cycle. The data confirm that chondrocyte activity is enhanced in OA and suggest that the increased Bcl-2/p53 ratio sustains the metabolic boost of chondrocytes.
Abbreviations: IGF, insulin-like growth factor; mAb, monoclonal antibody; OA, osteoarthritis; PBS, phosphate buffered saline
Keywords: Bcl-2; p53; Fas; apoptosis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Rothschild, B. M., Panza, R. K.
(2007). Lack of bone stiffness/strength contribution to osteoarthritis--evidence for primary role of cartilage damage. Rheumatology (Oxford)
46: 246-249
[Abstract] [Full Text] -
Surendran, S., Kim, S. H., Jee, B. K., Ahn, S. H., Gopinathan, P., Han, C. W.
(2006). Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis. J Bone Joint Surg Br
88-B: 1660-1665
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
